$EHC

3 theses
bullish 0%neutral 0%bearish 100%
Avg return (1y)
—
Win rate (1y)
— (0 resolved)

Past performance does not predict future results. Informational only, not investment advice.

Recent theses

Prices as of Sep 18, 4:30 PM ET
$EHCSEC Form 4bearish
Sold 18,869 @ $125.38 avg · $2,365,795 · 2026-08-10

Form 4: COLTHARP DOUGLAS E sold EHC

COLTHARP DOUGLAS E (EVP & Chief Financial Officer at Encompass Health Corp) reported an open-market sale of 18,869 shares of EHC at an average $125.38, roughly $2,365,795, in a Form 4 filed 2026-08-11.

At post $125.35Now $121.75-2.9% since postedas of Sep 18, 4:30 PM ET
1d-0.4%
3d-1.4%
1w-2.6%
1m-3.4%
3m—
6m—
1y—
View filing on SEC.gov →
$EHCSEC Form 4bearish
Sold 173,148 @ $125.47 avg · $21,724,095 · 2026-08-10

Form 4: Tarr Mark J sold EHC

Tarr Mark J (President & CEO at Encompass Health Corp) reported an open-market sale of 173,148 shares of EHC at an average $125.47, roughly $21,724,095, in a Form 4 filed 2026-08-11.

At post $125.35Now $121.75-2.9% since postedas of Sep 18, 4:30 PM ET
1d-0.4%
3d-1.4%
1w-2.6%
1m-3.4%
3m—
6m—
1y—
View filing on SEC.gov →
$EHCSEC Form 4bearish
Sold 8,906 @ $125.95 avg · $1,121,711 · 2026-08-10

Form 4: Darby John Patrick sold EHC

Darby John Patrick (EVP, Gen Counsel & Secretary at Encompass Health Corp) reported an open-market sale of 8,906 shares of EHC at an average $125.95, roughly $1,121,711, in a Form 4 filed 2026-08-11.

At post $125.35Now $121.75-2.9% since postedas of Sep 18, 4:30 PM ET
1d-0.4%
3d-1.4%
1w-2.6%
1m-3.4%
3m—
6m—
1y—
View filing on SEC.gov →

End of results.